Hospira reports another recall; Emergent ups BioThrax production;

> Alexion Pharmaceuticals ($ALXN), which has been expanding operations in Ireland, has raised its full-year profit forecast for the second time in less than two months, expecting particularly good sales of its orphan drug Soliris. Story

> Hospira ($HSP) is voluntarily recalling one lot of its 0.25% Marcaine because of particulates, which follows two other recalls this week. Release

> Thoughts on whether drug manufacturers should randomize serial numbers as they undertake track-and-trace. Blog Post

> Lucideon is building a new materials testing lab in Penkhull, U.K., targeted at the pharmaceutical industry. Item

> Emergent ($EBS) has started manufacturing its BioThrax anthrax vaccine adsorbed in a second building in Rockville, MD, as it works to get FDA approval of that manufacturing facility, which would allow it to triple production. Release

And Finally... Saturday is National Drug Take Back Day, when pharmacies and other collection sites around the country will allow you to drop off unused meds. Blog Post